Physician profile
Randi E Braman
NPI 1285645747
$7,309.65
in general payments reported to CMS, 2019-2025
48 companies · $976 in 2025
The $976 reported for 2025 was more than what 85% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $994 · 2020: $852 · 2021: $1,255 · 2022: $922 · 2023: $1,296 · 2024: $1,015 · 2025: $976.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,287.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,477.63 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $952.94 | 2019-2025 | Qulipta, Vraylar, Ubrelvy |
| Lilly USA, LLC | $789.22 | 2019-2025 | Mounjaro, Trulicity, Zepbound |
| Astrazeneca Pharmaceuticals LP | $423.34 | 2019-2025 | Breztri, Farxiga |
| Glaxosmithkline, LLC. | $370.92 | 2019-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Amgen INC. | $277.58 | 2019-2025 | Krystexxa, Prolia, Evenity |
| Merck Sharp & Dohme LLC | $238.93 | 2019-2025 | Capvaxive |
| Pfizer INC. | $232.42 | 2021-2025 | |
| Astellas Pharma US INC | $202.02 | 2019-2025 | Veozah |
| Biohaven Pharmaceuticals, INC. | $192.24 | 2021 | |
| Amarin Pharma, INC. | $186.18 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $173.33 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $171.71 | 2019-2025 | Jardiance, Ofev, Synjardy |
| Bayer Healthcare Pharmaceuticals INC. | $169.99 | 2021-2025 | |
| Exact Sciences Corporation | $168.95 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randi Braman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.